Literature DB >> 4261220

Additional studies on human C5: development of a modified purification method and characterization of the purified product by polyacrylamide gel electrophoresis.

U R Nilsson, R H Tomar, F B Taylor.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4261220     DOI： 10.1016/0019-2791(72)90015-8

Source DB:  PubMed          Journal:  Immunochemistry        ISSN： 0019-2791


× No keyword cloud information.
  26 in total

1.  Complement (C5-a)-induced granulocyte aggregation in vitro. A possible mechanism of complement-mediated leukostasis and leukopenia.

Authors:  P R Craddock; D Hammerschmidt; J G White; A P Dalmosso; H S Jacob
Journal:  J Clin Invest       Date:  1977-07       Impact factor: 14.808

2.  Phosphorylation of complement component C3 after synthesis in U937 cells by a putative protein kinase, casein kinase 2, which is regulated by CD11b: evidence that membrane-bound proteases preferentially cleave phosphorylated C3.

Authors:  K Nilsson Ekdahl; B Nilsson
Journal:  Biochem J       Date:  1997-12-01       Impact factor: 3.857

3.  Hereditary deficiency of the fifth component of complement in man. I. Clinical, immunochemical, and family studies.

Authors:  S I Rosenfeld; M E Kelly; J P Leddy
Journal:  J Clin Invest       Date:  1976-06       Impact factor: 14.808

4.  Digestion of the fifth component of complement by leukocyte enzymes. Sequential generation of chemotactic activities for leukocytes and for tumor cells.

Authors:  F W Orr; J Varani; D L Kreutzer; R M Senior; P A Ward
Journal:  Am J Pathol       Date:  1979-01       Impact factor: 4.307

5.  Hereditary deficiency of the seventh component of complement.

Authors:  J T Boyer; E P Gall; M E Norman; U R Nilsson; T S Zimmerman
Journal:  J Clin Invest       Date:  1975-10       Impact factor: 14.808

6.  The purification and characterization of bovine C4, the fourth component of complement.

Authors:  N A Booth; R D Campbell; J E Fothergill
Journal:  Biochem J       Date:  1979-03-01       Impact factor: 3.857

7.  Metabolism of the fifth component of complement, and its relation to metabolism of the third component, in patients with complement activation.

Authors:  J G Sissons; J Liebowitch; N Amos; D K Peters
Journal:  J Clin Invest       Date:  1977-04       Impact factor: 14.808

8.  C5 chemotactic fragment induces leukocyte production of tissue factor activity: a link between complement and coagulation.

Authors:  T W Muhlfelder; J Niemetz; D Kreutzer; D Beebe; P A Ward; S I Rosenfeld
Journal:  J Clin Invest       Date:  1979-01       Impact factor: 14.808

9.  Immunological analysis of plasminogen activators from cultured human cancer cells.

Authors:  S Naito; K Sueishi; F Hattori; K Tanaka
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1980

10.  Complement lysis of human erythrocytes. Differeing susceptibility of two types of paroxysmal nocturnal hemoglobinuria cells to C5b-9.

Authors:  C H Packman; S I Rosenfeld; D E Jenkins; P A Thiem; J P Leddy
Journal:  J Clin Invest       Date:  1979-08       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.